Senior Vice President of $CPSS sells 9,369 shares in insider transaction

Noel Jackson, serving as the Senior Vice President of $CPSS, recently made headlines by selling 9,369 shares of the company on 09-16-2025, fetching an estimated $79,578. This transaction was disclosed through a recent filing with the Securities and Exchange Commission (SEC). The sale represented the complete divestment of approximately 100.0% of their holdings in this class of stock, resulting in them holding 0 shares of this specific $CPSS stock class.

In the realm of $CPSS insider trading activities, the past six months have seen considerable movement within the company. $CPSS insiders engaged in nine open market trades during this period, with all nine transactions involving sales rather than purchases. Among these transactions, Greg Washer made seven sales totaling 25,689 shares, garnering approximately $251,080. Furthermore, April Crisp, another Senior Vice President, also sold 100 shares of $CPSS stock for an estimated $975.

On the front of $CPSS hedge fund activity, notable shifts have occurred in recent quarters. In the second quarter of 2025, 23 institutional investors decided to increase their positions in $CPSS stock, while 21 others opted to reduce their holdings. Some significant maneuvers in this domain include Highpoint Advisor Group LLC adding 33,343 shares (+31.0%) to their portfolio during Q2 2025, equating to around $327,761. Conversely, Goldman Sachs Group Inc. reduced its holdings by 18,949 shares (-59.7%) in the same quarter, resulting in an estimated $186,268 loss. Citadel Advisors LLC undertook a complete divestment, removing 18,176 shares (-100.0%) valued at $178,670 from their portfolio.

Additionally, Geode Capital Management, LLC added 16,563 shares (+8.5%) to their holdings, worth approximately $162,814, during Q2 2025. Concurrently, BlackRock, Inc. augmented its position by 12,548 shares (+2.0%), amounting to an estimated $123,346. Renaissance Technologies LLC, on the other hand, decided to reduce its holdings by 9,400 shares (-2.3%), resulting in a loss of around $92,402. Barclays PLC witnessed an uptick by adding 6,941 shares (+74.7%) to their portfolio, valuing at approximately $68,230.

For a comprehensive view of insider transactions and hedge funds’ stock portfolios, one can refer to Quiver Quantitative’s dedicated dashboards. However, it is imperative to note that the information contained in this article is not intended as financial advice, and readers are advised to review Quiver Quantitative’s disclaimers for detailed insights and precautions.